Enhancer of Zeste Homologue 2 (EZH2) may relate to progression of intra and extrahepatic cholangiocarcinoma

被引：0
|
作者：
Nakagawa, Shigeki [1 ]
Okabe, Hlrohisa [1 ]
Beppu, Toru [1 ]
Kuroki, Hideyuki [1 ]
Mima, Kousuke [1 ]
Hayashi, Hiromitu [1 ]
Imai, Katsunori [1 ]
Nitta, Hidetoshi [1 ]
Nakahara, Osamu [1 ]
Ikuta, Yoshiaki [1 ]
Chikamoto, Akira [1 ]
Ishiko, Takatoshi [1 ]
Takamori, Hiroshi [1 ]
Baba, Hideo [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1055
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration
    Bae, Woo Kyun
    Kang, Keunsoo
    Yu, Ji Hoon
    Yoo, Kyung Hyun
    Factor, Valentina M.
    Kaji, Kosuke
    Matter, Matthias
    Thorgeirsson, Snorri
    Hennighausen, Lothar
    FASEB JOURNAL, 2015, 29 (05): : 1653 - 1662
  • [32] Expression of enhancer of zeste homolog 2 (EZH2) in Invasive neuroendocrine carcinoma of the breast
    Gong, Y.
    Chen, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    HISTOPATHOLOGY, 2012, 61 : 20 - 20
  • [33] The Overexpression of Enhancer of Zeste Homolog 2 (EZH2) May Be Related to Malignant Behaviors in Intraductal Papillary Neoplasm of the Bile Duct
    Sasaki, M.
    Matsubara, T.
    Sato, Y.
    Yoneda, N.
    Nakanuma, Y.
    MODERN PATHOLOGY, 2012, 25 : 424A - 424A
  • [34] The Overexpression of Enhancer of Zeste Homolog 2 (EZH2) May Be Related to Malignant Behaviors in Intraductal Papillary Neoplasm of the Bile Duct
    Sasaki, M.
    Matsubara, T.
    Sato, Y.
    Yoneda, N.
    Nakanuma, Y.
    LABORATORY INVESTIGATION, 2012, 92 : 424A - 424A
  • [35] A systems approach identifies Enhancer of Zeste Homolog 2 (EZH2) as a protective factor in epilepsy
    Khan, Nadia
    Schoenike, Barry
    Basu, Trina
    Grabenstatter, Heidi
    Rodriguez, Genesis
    Sindic, Caleb
    Johnson, Margaret
    Wallace, Eli
    Maganti, Rama
    Dingledine, Raymond
    Roopra, Avtar
    PLOS ONE, 2019, 14 (12):
  • [36] Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
    Qi Zhang
    Peixin Dong
    Xishi Liu
    Noriaki Sakuragi
    Sun-Wei Guo
    Scientific Reports, 7
  • [37] Enhancer of zeste homolog 2 (EZH2) in endocrine tumors: current knowledge and future directions
    Kumari, Poonam
    Garg, Sheenam
    Arya, Ashutosh Kumar
    Kaur, Jyotdeep
    Sachdeva, Naresh Kumar
    Saikia, Uma Nahar
    Dahiya, Divya
    Bhadada, Sanjay Kumar
    Rao, Sudhaker D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2025, 29 (03) : 159 - 169
  • [38] Significant association of enhancer of zeste 2 (EZH2) genotypes with bladder cancer risk in Taiwan
    Liao, Cheng-Hsi
    Chang, Wen-Shin
    Wu, Hsi-Chin
    Tsai, Chia-Wen
    Bau, Da-Tian
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 324 - 324
  • [39] Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
    Dahlby, Tina
    Simon, Christian
    Backe, Marie Balslev
    Dahllof, Mattias Sailing
    Holson, Edward
    Wagner, Bridget K.
    Boni-Schnetzler, Marianne
    Marzec, Michal Tomasz
    Lundh, Morten
    Mandrup-Poulsen, Thomas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 18
  • [40] Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
    Ciarapica, Roberta
    Miele, Lucio
    Giordano, Antonio
    Locatelli, Franco
    Rota, Rossella
    BMC MEDICINE, 2011, 9
12345